A paclitaxel and microRNA-124 coloaded stepped cleavable nanosystem against triple negative breast cancer

BACKGROUND: Triple negative breast cancer (TNBC) is one of the most biologically aggressive breast cancers and lacks effective treatment options, resulting in a poor prognosis. Therefore, studies aiming to explore new therapeutic strategies for advanced TNBC are urgently needed. According to recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chuanrong, Shen, Ming, Liao, Hongze, Guo, Qianqian, Fu, Hao, Yu, Jian, Duan, Yourong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905927/
https://www.ncbi.nlm.nih.gov/pubmed/33632232
http://dx.doi.org/10.1186/s12951-021-00800-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905927/
https://www.ncbi.nlm.nih.gov/pubmed/33632232
http://dx.doi.org/10.1186/s12951-021-00800-z

Ejemplares similares